TBMC
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

TBMC Trademark

Serial Number: 99578022

TBMC is a trademark filed by Taiwan Bio-Manufacturing Corporation on January 5, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Taiwan Bio-Manufacturing Corporation (3 trademarks)

3 F.-6, No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist.
Taipei City 115 , TW

Entity Type: 99

Trademark Details

Filing Date

January 5, 2026

Registration Date

Not Registered

Published for Opposition

June 9, 2026

Goods & Services

Research and development in the field of bacteriology, biological preparations, biochemistry, biotechnology, biomedicine, chemical preparations, cell therapies, gene therapies, gene expression systems, medical preparations, microorganisms and cells, medicines, mRNA, oligonucleotides, pharmaceuticals, pharmaceutical preparations, proteins viral vectors, and vaccines; Product research and development; Medical and scientific research, namely, conducting clinical trials for others; Research and development of drug conjugates; Research and development of mRNA drugs; Pharmaceutical product evaluation; Conducting early evaluations in the field of new pharmaceuticals; Product quality testing services

Industrial chemicals; Chemicals for use in industry and science; Biological preparations for use in industry and science; Biological preparation for use in cell cultures other than for medical or veterinary use; Biological preparations for use in the manufacture of pharmaceuticals

Biopharmaceuticals, namely, antibodies and proteins for medical and pharmaceutical use for the treatment of cancer, cardiovascular, hematologic, neurological, gastrointestinal, and genetic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, coagulation disorders, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine, nutritional and metabolic diseases, mental, behavioral, and neurodevelopmental disorders, sleep-wake disorders, diseases of the nervous system, diseases of the respiratory system, diseases of the digestive system, and diseases of the skin; Biological preparations for use in science, namely, primary cells, cell cultures and transfection products in the nature of human and animal cells for medical and clinical use in human and animal therapies for the treatment of cancer, cardiovascular, hematologic, neurological, gastrointestinal, and genetic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, coagulation disorders, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine, nutritional and metabolic diseases, mental, behavioral, and neurodevelopmental disorders, sleep-wake disorders, diseases of the nervous system, diseases of the respiratory system, diseases of the digestive system, and diseases of the skin; Pharmaceutical preparations for human purposes, namely, medicines for the treatment of cancer, and cardiovascular, hematologic, neurological, gastrointestinal and genetic diseases; Vaccines; Reagents for medical purposes; Pharmaceutical preparations for promoting hair growth; Biological preparations for medical and pharmaceutical use, namely, genetically modified cells, genetic material and vectors, namely, cosmids, plasmids, viral material, or chromosomes for production of human, animal, and synthetic proteins for medical and clinical use; Pharmaceutical preparations, namely, human or animal blood, tissue, blood cells, and stem-cells for medical and clinical use; Biological preparations for the treatment of cancer, cardiovascular, hematologic, neurological, gastrointestinal, and genetic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, coagulation disorders, infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs, endocrine, nutritional and metabolic diseases, mental, behavioral, and neurodevelopmental disorders, sleep-wake disorders, diseases of the nervous system, diseases of the respiratory system, diseases of the digestive system, and diseases of the skin; Biological reagents for veterinary purposes; Amino acid preparations for veterinary purposes; Antibodies for veterinary purposes; Cultures of microorganisms for medical or veterinary use

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 9, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jun 9, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 3, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 8, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
May 8, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 8, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
May 8, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 8, 2026 CNEA
ASSIGNED TO EXAMINER
May 4, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 23, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Jan 5, 2026 MAFR
NEW APPLICATION ENTERED
Jan 5, 2026 NWAP